期刊文献+

炎琥宁在大鼠体内血药浓度测定方法及其药动学研究 被引量:4

Determination Method of Plasma Level of Potassium Sodium in Rat and Study on Its Pharmacokinetics
原文传递
导出
摘要 目的:建立以高效液相色谱(HPLC)法测定大鼠血浆中炎琥宁含量的方法,并对其药动学进行研究。方法:色谱柱为VP-ODS C18 Column(150mm×4.6mm,5μm),流动相为甲醇-1%醋酸-三乙胺(65∶35∶0.02),内标物为安定,流速为1.0mL·min-1,检测波长为251nm,温度为40℃。用甲醇沉淀蛋白后取上清液过0.45μm微孔滤膜进样分析,采用DAS1.0软件进行药动学参数估算。结果:炎琥宁进样浓度分别在0.05~1.0μg·mL-1(r=0.9999)和1.0~10.0μg·mL-1(r=0.9998)范围内与各自峰面积积分值之比呈良好线性关系;平均回收率为90.12%,RSD=0.508%(n=3)。大鼠静脉注射4mg·kg-1炎琥宁后,其tmax、Cmax、t1/2α和AUC0~240分别为(5.03±1.2)min、(1.09±7.5)mg·L-1、(0.95±4.4)min和(18.14±1.1)mg·min·L-1。结论:炎琥宁在大鼠体内的药动学过程符合二室模型。 OBJECTIVE: To determine plasma level of Potassium sodium in rat by a reversed phase high performance chromatographic method(RP- HPLC) and to study its pharmaeokinetics.METHODS: The plasma was deproteinized with methanol that contained an internal standard (diazepamum) and was separated.The plasma samples were chromatographed on VP- ODS C18(150 mm × 4.6 mm, 5 μm) column with a mobile phase consisting of methanol - 1% acetic acid- triethylamine (65 : 35 : 0.02) and detected at 251 nm.The flow - rate was 1.0 mL · min^- 1 and the column temperature was set at 40 ℃ . After deproteinization of plasma, supernatant was taken to be filtered through 0.45 μm microporous membrane for analysis.The pharmacokinetics parameters were calculated using DAS 1.0 Software. RESULTS: The linear calibration curve of Potassium sodium in plasma at a concentration range from 0.05 to 1.0 μg · ml^-1(r = 0.999 9) and 1.0 to 10.0μg · ml^- 1( r = 0.999 8).The average recovery of Potassium sodium was 90.12% (RSD = 0. 508%, n = 3).The pharmacokinetie parameters of Potassium sodium in rats after iv. at a dose of 4 mg · kg^- 1 were as follows: tmax, Cmax,t1/ 2α and AUC0-240 were 5.03± 1.2 min, 1.09± 7.5 mg · L^-1, (0.95± 4.4) rain and(18.14± 1.1) mg · min· L^- 1, respectively.CONCLUSION: The pharmaeokinetics of Potassium sodium in rats fits the two- compartment model.
出处 《中国药房》 CAS CSCD 北大核心 2008年第36期2814-2815,共2页 China Pharmacy
关键词 炎琥宁 高效液相色谱法 血浆 药动学 Potassium sodium HPLC Plasma Pharmacokinetics
  • 相关文献

参考文献1

二级参考文献1

共引文献18

同被引文献21

  • 1王宝灿,岳彩连.炎琥宁治疗病毒性肺炎38例疗效观察[J].山东医药,2004,44(31):48-48. 被引量:9
  • 2戴桂馥,王俊峰,徐海伟,郭志军,杨莹,刘宏民.穿心莲内酯对人食管癌Ec9706细胞增殖和凋亡的影响[J].中国新药杂志,2006,15(16):1363-1365. 被引量:11
  • 3周爱萍,孙燕.多靶点抗肿瘤新药索拉非尼的研究进展[J].癌症进展,2006,4(6):529-533. 被引量:57
  • 4郑虎占.中药现代研究与应用[M].北京:学苑出版社,1998.1484-2373.
  • 5Kumar RA, Sridevi K, Kumar NV, et al. Anticancer and immunostimulatory compounds from Andrographis panic- ulata[J]. JEthnopharmacol, 2004, 92(?./3) :291.
  • 6Matsuda T, Kuroyanagi M, Sugiyama S, et al. Cell dif- ferentiation-inducing diterpenes from Andrographis panic- ulata Nees[J]. Chem Pharm Bull, 1994,42(6) : 1 216.
  • 7Cheung HY, Cheung SH, Li J, et al. Andrographolide is- olated from Andrographis paniculata induces cell cycle ar- rest and mitochondrial-mediated apoptosis in human leu- kemic HL-60 cells[J]. Planta Med, 2005,71 (12) : 1 106.
  • 8Jiang CG, Li J B, Liu RR, et al. Andrographolide inhibi- tis the adhesion of gastric cancer cells to endothelial cells by blocking E-selecting expression[J]. Anticancer Res, 2007.27(4B) :2 439.
  • 9AFIFY S, RAPP UR, HOGGER P. Validation of a liquid chromatography assay for the quantifucation of the Raf kinase inhibitor BAY 43-9006 in small volumes of mouse serum[J]. J Chromatoqr B Analyt Technol Biomed Life Sci, 2004, 809(1): 99-103.
  • 10HEINZ W J, KAHLE K, HELLE-BEYERSDORF A, et al. High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid (1]. Cancer Chemother Pharmacol, 2011, 68( I): 239-245.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部